L Deneux

1.1k total citations
17 papers, 838 citations indexed

About

L Deneux is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, L Deneux has authored 17 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in L Deneux's work include Genetic factors in colorectal cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Skin and Cellular Biology Research (2 papers). L Deneux is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Skin and Cellular Biology Research (2 papers). L Deneux collaborates with scholars based in France, United States and Australia. L Deneux's co-authors include Suzy Scholl, François Le Naour, David E. Misek, Thomas J. Giordano, Samir Hanash, Wolf H. Fridman, Éric Tartour, P Pouillart, Véronique Mosseri and Thierry Dorval and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

L Deneux

16 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Deneux France 11 378 344 316 130 98 17 838
Kumiko Nagashima United States 10 540 1.4× 257 0.7× 723 2.3× 62 0.5× 131 1.3× 11 1.2k
Alexei L. Krasnoselsky United States 13 591 1.6× 153 0.4× 168 0.5× 146 1.1× 159 1.6× 15 1.0k
Michaela Herzig Austria 10 816 2.2× 457 1.3× 129 0.4× 82 0.6× 148 1.5× 10 1.2k
Ashley M. Smith United States 8 441 1.2× 269 0.8× 371 1.2× 128 1.0× 38 0.4× 14 1.4k
Guenther Stockhammer Austria 11 194 0.5× 139 0.4× 198 0.6× 124 1.0× 80 0.8× 24 726
Gerard Cowley United Kingdom 16 399 1.1× 426 1.2× 200 0.6× 175 1.3× 122 1.2× 27 1.0k
Gabrielle M. Siegers Canada 20 330 0.9× 409 1.2× 554 1.8× 83 0.6× 91 0.9× 41 1.0k
Michiko Harao Japan 16 362 1.0× 329 1.0× 377 1.2× 87 0.7× 132 1.3× 36 915
Agnes S. Lo United States 20 418 1.1× 505 1.5× 599 1.9× 97 0.7× 100 1.0× 28 1.4k
Danielle Ulanet United States 12 647 1.7× 169 0.5× 342 1.1× 98 0.8× 182 1.9× 23 1.2k

Countries citing papers authored by L Deneux

Since Specialization
Citations

This map shows the geographic impact of L Deneux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Deneux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Deneux more than expected).

Fields of papers citing papers by L Deneux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Deneux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Deneux. The network helps show where L Deneux may publish in the future.

Co-authorship network of co-authors of L Deneux

This figure shows the co-authorship network connecting the top 25 collaborators of L Deneux. A scholar is included among the top collaborators of L Deneux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Deneux. L Deneux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pionneau, Cédric, et al.. (2005). An efficient proteomics-based approach for the screening of autoantibodies. Journal of Immunological Methods. 299(1-2). 77–89. 52 indexed citations
2.
Pierga, Jean‐Yves, L Deneux, Anne Vincent‐Salomon, et al.. (2004). Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients. The International Journal of Biological Markers. 19(1). 23–31. 7 indexed citations
3.
Pierga, Jean‐Yves, L Deneux, Anne Vincent‐Salomon, et al.. (2004). Prognostic Value of Cytokeratin 19 Fragment (CYFRA 21–1) and Cytokeratin-Positive Cells in Bone Marrow Samples of Breast Cancer Patients. The International Journal of Biological Markers. 19(1). 23–31.
4.
Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2003). Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000. British Journal of Cancer. 89(S1). S32–S34. 9 indexed citations
5.
Pagès, Franck, Sophie Lebel‐Binay, Annick Vieillefond, et al.. (2002). Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer. Clinical & Experimental Immunology. 127(2). 303–309. 16 indexed citations
6.
McDermott, Ray, L Deneux, Véronique Mosseri, et al.. (2002). Circulating macrophage colony stimulating factor as a marker of tumour progression.. PubMed. 13(1). 121–7. 73 indexed citations
7.
Eche, N., M. Pichon, Véronique Quillien, et al.. (2001). [Standards, options and recommendations for tumor markers in colorectal cancer].. PubMed. 88(12). 1177–206. 14 indexed citations
8.
Naour, François Le, David E. Misek, L Deneux, et al.. (2001). Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.. PubMed. 7(11). 3328–35. 280 indexed citations
9.
Pichon, M., J P Basuyau, N. Eche, et al.. (2001). [Standards, options and recommendations for blood tumor markers in thyroid cancers].. PubMed. 88(8). 775–92. 10 indexed citations
10.
Scholl, Suzy, Nadine Bizouarne, Marie Paule Kiény, et al.. (2000). Recombinant Vaccinia Virus Encoding Human MUC1 and IL2 as Immunotherapy in Patients With Breast Cancer. Journal of Immunotherapy. 23(5). 570–580. 108 indexed citations
11.
Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2000). [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].. PubMed. 87(10). 723–37. 16 indexed citations
12.
Thiounn, Nicolas, Franck Pagès, T Flam, et al.. (1997). IL-6 is a survival prognostic factor in renal cell carcinoma. Immunology Letters. 58(2). 121–124. 41 indexed citations
13.
Tartour, Éric, L Deneux, Véronique Mosseri, et al.. (1997). Soluble interleukin‐2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma. Cancer. 79(7). 1401–1408. 2 indexed citations
14.
Tartour, Éric, L Deneux, Véronique Mosseri, et al.. (1997). Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma. Cancer. 79(7). 1401–1408. 29 indexed citations
15.
Tartour, Éric, Jean‐Yves Blay, Thierry Dorval, et al.. (1996). Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.. Journal of Clinical Oncology. 14(5). 1697–1703. 77 indexed citations
16.
Matias, Jorge Eduardo Fouto, et al.. (1995). [Serum marker of the functional hepatic mass after extensive hepatectomy. The branched/aromatic amino acid ratio. Experimental and clinical studies].. PubMed. 120(5). 283–8. 6 indexed citations
17.
Tartour, Éric, Thierry Dorval, Véronique Mosseri, et al.. (1994). Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. British Journal of Cancer. 69(5). 911–913. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kumiko Nagashima Breakdown of academic impact, for papers by Alexei L. Krasnoselsky Breakdown of academic impact, for papers by Michaela Herzig Breakdown of academic impact, for papers by Ashley M. Smith Breakdown of academic impact, for papers by Guenther Stockhammer Breakdown of academic impact, for papers by Gerard Cowley Breakdown of academic impact, for papers by Gabrielle M. Siegers Breakdown of academic impact, for papers by Michiko Harao Breakdown of academic impact, for papers by Agnes S. Lo Breakdown of academic impact, for papers by Danielle Ulanet
Rankless by CCL
2026